These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17998643)

  • 1. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
    Sebastián Villalón-López J; Arturo Valle-Mejía C; Patiño-Lara A; Moreno-Pérez Bertha A; Alejo Muñoz-López J; Alcantar-Andrade A
    J Cancer Res Ther; 2005; 1(3):132-5. PubMed ID: 17998643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
    Villalon-Lopez JS; Valle-Mejia CA; Patino-Lara A; Moreno-Perez BA; Munoz-Lopez JA; Alcantar-Andrade A
    J Cancer Res Ther; 2006; 2(3):140-3. PubMed ID: 17998694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary basosquamous carcinoma of the lower eyelid with ocular invasion A case report.
    Papadopoulos GO; Charitonidi E; Filippou N; Fanidou D; Filippou D; Scandalakis P
    Ann Ital Chir; 2018 Mar; 7():. PubMed ID: 29626183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed (nodular and morpheic) upper eyelid basal cell carcinoma with orbital invasion - histological and clinical features.
    Costan VV; Tamaş C; Dobrin N; Costache DA; Ciocoiu M
    Rom J Morphol Embryol; 2018; 59(3):977-983. PubMed ID: 30534843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exenteration of the Orbit for Basal Cell Carcinoma].
    Furdová A; Horkovičová K; Krčová I; Krásnik V
    Cesk Slov Oftalmol; 2015 Aug; 71(4):209-16. PubMed ID: 26395856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
    Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
    Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtotal Exenteration of the Orbit for Benign Orbital Disease.
    Furdova A; Babal P; Zahorjanova P; Sekac J
    J Craniofac Surg; 2020; 31(5):1367-1369. PubMed ID: 32224777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
    Sagiv O; Ding S; Ferrarotto R; Glisson B; Altan M; Johnson F; Elamin Y; Thakar SD; Nagarajan P; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2019; 35(4):350-353. PubMed ID: 30365473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston Lecture.
    Shields JA; Shields CL; Demirci H; Honavar SG; Singh AD
    Ophthalmic Plast Reconstr Surg; 2001 Sep; 17(5):355-61. PubMed ID: 11642492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Metastatic Eyelid Carcinoma.
    Bonavolontà P; Dell'Aversana Orabona G; Abbate V; Iaconetta G; Bonavolontà G; Califano L
    J Craniofac Surg; 2017 Nov; 28(8):e722-e725. PubMed ID: 28885435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbital exenteration for secondary orbital tumors: a series of seven cases.
    Lin HF; Lui CC; Hsu HC; Lin SA
    Chang Gung Med J; 2002 Sep; 25(9):599-605. PubMed ID: 12479621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital exenteration for invasive skin tumours.
    Tyers AG
    Eye (Lond); 2006 Oct; 20(10):1165-70. PubMed ID: 17019414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RECURRENT PERIOCULAR BASAL CELL CARCINOMA. CASE REPORT.
    Prídavková Z; Bieliková A; Ferková N; Lysková D
    Cesk Slov Oftalmol; 2021; 77(4):208-213. PubMed ID: 34507497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. I. Characteristics of the tumours and details of the procedure.
    Lindgren G; Lindblom B; Bratel AT; Mölne L; Larkö O
    Acta Ophthalmol Scand; 2000 Aug; 78(4):425-9. PubMed ID: 10990045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orbital invasion by periocular basal cell carcinoma.
    Leibovitch I; McNab A; Sullivan T; Davis G; Selva D
    Ophthalmology; 2005 Apr; 112(4):717-23. PubMed ID: 15808267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update.
    Cook BE; Bartley GB
    Ophthalmology; 2001 Nov; 108(11):2088-98; quiz 2099-100, 2121. PubMed ID: 11713084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orbital exenteration. A preventable course in tumor treatment?!].
    Schayan-Araghi K; Press UP; Hübner H
    Ophthalmologe; 1994 Aug; 91(4):536-9. PubMed ID: 7950131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.
    Furdova A; Lukacko P
    J Craniofac Surg; 2017 Jan; 28(1):e84-e87. PubMed ID: 27906855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell carcinoma of the head and neck.
    Nakayama M; Tabuchi K; Nakamura Y; Hara A
    J Skin Cancer; 2011; 2011():496910. PubMed ID: 21209728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Destruction of the orbit and globe by recurrence of basal cell carcinoma.
    Chew R
    Optometry; 2007 Jul; 78(7):344-51. PubMed ID: 17601572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.